MBX Biosciences Files Q1 2025 10-Q
Ticker: MBX · Form: 10-Q · Filed: May 12, 2025 · CIK: 1776111
Sentiment: neutral
Topics: 10-Q, financials, preferred-stock, agreements
TL;DR
MBX Biosciences Q1 10-Q is out. Shows preferred stock, ESPP, and a Jan 16 research deal.
AI Summary
MBX Biosciences, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its financial position and business operations. Key events and disclosures include details on convertible preferred stock, employee stock purchase plans, and a research agreement dated January 16, 2025.
Why It Matters
This filing provides investors with an update on MBX Biosciences' financial health and operational status for the first quarter of 2025, including details on preferred stock and agreements.
Risk Assessment
Risk Level: medium — The filing contains information about convertible preferred stock and a research agreement, which can indicate potential future dilution or R&D-related risks.
Key Numbers
- 2025-03-31 — Reporting Period End (Quarterly financial update)
- 2025-05-12 — Filing Date (Date the report was submitted)
Key Players & Entities
- MBX Biosciences, Inc. (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250512 (date) — Filing Date
- SeriesAConvertiblePreferredStockMember (company) — Financial Instrument
- SeriesBConvertiblePreferredStockMember (company) — Financial Instrument
- TwoThousandTwentyFourEmployeeStockPurchasePlanMember (company) — Employee Plan
- ResearchAgreementMember (company) — Agreement
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 12, 2025.
What types of convertible preferred stock are mentioned?
The filing mentions Series A Convertible Preferred Stock and Series B Convertible Preferred Stock.
Is there any mention of employee stock plans?
Yes, the 'TwoThousandTwentyFourEmployeeStockPurchasePlanMember' is mentioned in relation to March 31, 2025.
What is the date of the mentioned Research Agreement?
The Research Agreement is dated January 16, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding MBX Biosciences, Inc. (MBX).